PDCD1 and cancer: The discovery of inhibitors to target checkpoint proteins, such as anti-programmed cell death protein-1/ligand-1 (PD-1/PDL-1) and CTLA-4, has revolutionized cancer immunotherapy and played a major role in the management of various solid tumors.